Abstract:ABSTRACT The bone is the third most common site of metastasis for a wide range of solid tumors including lung, breast, prostate, colorectal, thyroid, gynecologic, and melanoma, with 70% of metastatic prostate and breast cancer patients harboring bone metastasis.1 Unfortunately, once cancer spreads to the bone, it is rarely cured and is associated with a wide range of morbidities including pain, increased risk of fracture, and hypercalcemia. This fact has driven experts in the fields of bone and cancer biology to study the bone, and has revealed that there is a great deal that each can teach the other. The complexity of the bone was first described in 1889 when Stephen Paget proposed that tumor cells have a proclivity for certain organs, where they “seed” into a friendly “soil” and eventually grow into metastatic lesions. Dr. Paget went on to argue that although many study the “seed” it would be paramount to understand the “soil.” Since this original work, significant advances have been made not only in understanding the cell‐autonomous mechanisms that drive metastasis, but also alterations which drive changes to the “soil” that allow a tumor cell to thrive. Indeed, it is now clear that the “soil” in different metastatic sites is unique, and thus the mechanisms that allow tumor cells to remain in a dormant or growing state are specific to the organ in question. In the bone, our knowledge of the components that contribute to this fertile “soil” continues to expand, but our understanding of how they impact tumor growth in the bone remains in its infancy. Indeed, we now appreciate that the endosteal niche likely contributes to tumor cell dormancy, and that osteoclasts, osteocytes, and adipocytes can impact tumor cell growth. Here, we discuss the bone microenvironment and how it impacts cancer cell seeding, dormancy, and growth. © 2018 American Society for Bone and Mineral Research.

TGF-β and BMP7 Interactions in Tumour Progression and Bone Metastasis

Bone Morphogenetic Proteins, Breast Cancer, and Bone Metastases: Striking the Right Balance

Bone morphogenetic protein and bone metastasis, implication and therapeutic potential.

Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review)

Tgf-Beta Signaling In Breast Cancer Cell Invasion And Bone Metastasis

TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis

Bone Morphogenetic Proteins and Their Receptor Signaling in Prostate Cancer.

Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications.

TGF-β signalling and its role in cancer progression and metastasis

The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment

When BMP Signalling Goes Wrong: the Intracellular and Molecular Mechanisms of BMP Signalling in Cancer

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

Understanding the Bone in Cancer Metastasis

Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis

Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.

Novel approaches to target the microenvironment of bone metastasis

Molecular Mechanisms of Breast Cancer Metastases to Bone

Metastatic bone disease: Pathogenesis and therapeutic options

Bone marrow niches in the regulation of bone metastasis

Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts

Chapter 6 Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer